80 Participants Needed

GPT-based Counseling for Gestational Diabetes

(AIM-GDM Trial)

Recruiting at 1 trial location
AA
Overseen ByAvish Arora, MD/PhD
Age: 18 - 65
Sex: Female
Trial Phase: Academic
Sponsor: Montefiore Medical Center
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial tests whether an AI-based counseling service can help manage gestational diabetes, a type of diabetes that occurs during pregnancy. Participants will receive either regular nutritional counseling or the same counseling with added AI support, known as GPT-based Nutrition and Diabetic Counseling. The trial aims to determine if the AI can make managing gestational diabetes easier and more effective. Pregnant women diagnosed with gestational diabetes who can use a smartphone and speak English or Spanish are well-suited for this study. As an unphased study, this trial provides a unique opportunity to explore innovative AI support in managing gestational diabetes.

Do I need to stop my current medications for this trial?

The trial information does not specify whether you need to stop taking your current medications.

What prior data suggests that this AI-based counseling service is safe for managing gestational diabetes?

Research has shown that using AI, such as GPT-based counseling, for managing gestational diabetes is generally safe and well-received. Studies have found that AI can assist in managing diabetes by identifying issues like high blood pressure and high cholesterol, which can increase diabetes risk. Importantly, these studies did not report any serious side effects from using AI in diabetes care.

This suggests that using AI for nutrition and diabetes counseling, as in this trial, is likely safe. Since the trial does not involve testing a new drug or any invasive procedures, the risk of negative effects remains low. Participants can feel assured that the AI-based approach is safe and may help improve blood sugar control during pregnancy.12345

Why are researchers excited about this trial?

Researchers are excited about GPT-based counseling for gestational diabetes because it leverages artificial intelligence to provide personalized nutrition and diabetes management advice. Unlike traditional methods that rely heavily on face-to-face interactions with healthcare providers, this approach uses AI to deliver tailored guidance, potentially making it more accessible and convenient for expectant mothers. Additionally, it offers the possibility of real-time adjustments to dietary and lifestyle recommendations, which could improve blood sugar control more effectively than current standard care options.

What evidence suggests that GPT-based counseling is effective for gestational diabetes?

This trial will compare GPT-based Nutrition and Diabetic Counseling with standard Nutritional Counseling for managing gestational diabetes. Research has shown that AI-driven diet advice can effectively manage diabetes by maintaining normal blood sugar levels. This guidance could reduce risks for both mothers and babies during pregnancy. In a past study, AI-based advice improved blood sugar control in pregnant women with diabetes. Additionally, AI tools have successfully educated individuals on managing type 2 diabetes. These findings suggest that AI, such as GPT, might enhance diabetes management during pregnancy by providing improved diet and lifestyle tips.12346

Who Is on the Research Team?

DM

Dimitrios Mastrogiannis, MD

Principal Investigator

Albert Einstein College of Medicine

Are You a Good Fit for This Trial?

This trial is for women aged 18-45 who have been diagnosed with gestational diabetes during pregnancy. Participants must be able to use a smartphone and speak English or Spanish fluently.

Inclusion Criteria

I am a woman aged between 18 and 45.
Diagnosed with GDM in pregnancy
Able to use a smartphone

Exclusion Criteria

High-risk pregnancies due to other medical conditions
No smartphone access
I am unable to give consent by myself.
See 1 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive nutritional counseling with or without AI intervention for gestational diabetes management

Throughout pregnancy until delivery

Follow-up

Participants are monitored for safety and effectiveness after treatment

4 weeks post-delivery

What Are the Treatments Tested in This Trial?

Interventions

  • GPT-based Nutrition and Diabetic Counseling
Trial Overview The AIM-GDM trial is testing if AI-based counseling, alongside nutritional advice, helps manage gestational diabetes better than current standard care practices.
How Is the Trial Designed?
2Treatment groups
Experimental Treatment
Active Control
Group I: Nutritional Counseling plus AI InterventionExperimental Treatment2 Interventions
Group II: Nutritional CounselingActive Control1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Montefiore Medical Center

Lead Sponsor

Trials
468
Recruited
599,000+

Published Research Related to This Trial

A study involving 180 gestational diabetes mellitus (GDM) patients showed that interdisciplinary health education combined with personalized nutrition significantly reduced fasting blood glucose (FPG), two-hour postprandial glucose (2hPBG), and glycated hemoglobin (HbA1C) levels compared to routine care.
The intervention also led to improved psychological scores (SDS and SAS) after treatment, indicating better overall management of GDM, although the difference in pregnancy outcomes between the two groups was not statistically significant.
The effect of interdisciplinary and diversified health education combined with personalized nutrition intervention on FPG, 2hPG, SDS, SAS scores and the pregnancy outcomes of gestational diabetes mellitus.Zhu, GH., Xu, Y., Zou, L., et al.[2021]
A clinical trial involving 215 women with gestational diabetes showed that following specific nutrition practice guidelines led to less insulin use and better control of glycated hemoglobin levels in diabetes clinic settings compared to usual care.
Women receiving care under the nutrition practice guidelines had a lower proportion of elevated glycated hemoglobin levels (8.1%) compared to those in the usual care group (13.6%), suggesting that these guidelines may improve management of gestational diabetes.
Impact of gestational diabetes mellitus nutrition practice guidelines implemented by registered dietitians on pregnancy outcomes.Reader, D., Splett, P., Gunderson, EP.[2022]
Medical nutrition therapy is essential for managing gestational diabetes mellitus (GDM), focusing on meeting the nutritional needs of both mother and fetus while maintaining optimal blood sugar levels.
Current guidelines recommend a balanced diet for women with GDM, but there is still debate over the best dietary compositions and weight management strategies, highlighting the need for further research to optimize treatment outcomes.
Gestational diabetes and nutritional recommendations.Gunderson, EP.[2019]

Citations

A Randomized Controlled Trial (AIM-GDM)Clinical trial for Gestational Diabetes , Evaluating the Efficacy of GPT-based Nutrition and Diabetic Counseling in Gestational Diabetes ...
2.trials-api.montefioreeinstein.orgtrials-api.montefioreeinstein.org/node/413271
A Randomized Controlled Trial (AIM-GDM)The purpose of this study is to assess whether an AI based counseling service can be beneficial for patients to assist in management of ...
Artificial intelligence in diabetes management - PubMed CentralAI-based diet recommendations​​ A proper diet is indispensable in managing diabetic patients by maintaining normal blood sugar levels and reducing the burden of ...
A Randomized Controlled Trial (AIM-GDM)Potential benefits of participating in this study include improved blood sugar control during pregnancy, which can reduce risks to both the mother and baby.
The Effectiveness of a Custom AI Chatbot for Type 2 ...This study aimed to evaluate the effectiveness of a custom RAG-based artificial intelligence chatbot designed to improve health literacy on type 2 diabetes ...
LLM-Based Support for Diabetes DiagnosisThis experiment investigates GPT-5's ability to interpret oral glucose tolerance test. (OGTT) results for gestational diabetes mellitus (GDM).
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security